Nixon Peabody Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
6,825
+2
| +0% | +$371 | 0.1% | 85 |
|
|
2025
Q1 | $1.43M | Buy |
6,823
+331
| +5% | +$69.4K | 0.12% | 76 |
|
|
2024
Q4 | $1.15M | Sell |
6,492
-330
| -5% | -$58.6K | 0.1% | 75 |
|
|
2024
Q3 | $1.35M | Hold |
6,822
| – | – | 0.11% | 68 |
|
|
2024
Q2 | $1.17M | Hold |
6,822
| – | – | 0.1% | 68 |
|
|
2024
Q1 | $1.24M | Sell |
6,822
-308
| -4% | -$56.1K | 0.11% | 62 |
|
|
2023
Q4 | $1.1M | Buy |
+7,130
| New | +$1.1M | 0.12% | 62 |
|
|
2022
Q2 | – | Sell |
-1,863
| Closed | -$302K | – | 70 |
|
|
2022
Q1 | $302K | Sell |
1,863
-1,200
| -39% | -$195K | 0.1% | 67 |
|
|
2021
Q4 | $415K | Sell |
3,063
-1,607
| -34% | -$218K | 0.13% | 67 |
|
|
2021
Q3 | $504K | Buy |
+4,670
| New | +$504K | 0.18% | 61 |
|